Description:

MAJOR PROJECTS AND RESEARCH DAY TWO /// 1pm - Psychedelic Medicine: The Known Knowns, Known Unknowns, and Unknown Unknowns. by: Rachel Yehuda, PhD, Vice Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai; Eric Vermetten, PhD, Military Mental Health Research Unit of the University Medical Center in the Netherlands; & Alex Sherwood, PhD, Medical Chemist, Usona /// 2pm - Usona Overview / Psilocybin FDA Approval Status by: Bill Linton, Founder and ED of Usona; Pancho Meisenheimer, PhD, Scientific Advisor, Usona; Alex Sherwood, PhD, Medical Chemist, Usona /// 3pm - Ayahuasca for Grief Therapy by: Debora Gonzalez, PhD, Research Scientist, International Center for Ethnobotanical Education, Research & Service (ICEERS) /// 4pm - Somatic-Focused Ketamine & Cannabis-Assisted Therapy for PTSD by: Rafael Lancelotta, Therapist, Innate Path /// 5pm - NYU/Heffter Overview of Psilocybin Therapy for Depression, Addiction, and Religious Professionals by: Stephen Ross, MD Co-Director, NYU Psychedelic Research Group